cognos-therapeutics-medical-device-technology-neuropathic-disease-mitagation-clinical-trail-herceptin-featured-image
Recent Posts
- Nocturne Acquisition Engages Chardan As Capital Markets Advisor for Cognos Acquisition
- Nocturne Acquisition Files S-4 In Advance Of Cognos’ NASDAQ Listing
- Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq
- Labroot’s Report Focuses on the Need To Develop Better Methods To Deliver Therapeutics to the Brain
- Cognos Co-Founder and CIO Josh Shachar Discusses The Evolution of the Cognos Vision
Recent Comments